Highlights

HLBank Research Highlights

Author: HLInvest   |   Latest post: Fri, 18 Jun 2021, 9:58 AM

 

UEM Edgenta - A Glimpse Into Its Digital Healthcare Foray

Author:   |    Publish date:


We explore Edgenta’s foray into digital healthcare, which begins with the launch of QuickMed (a digital healthcare platform aimed at digitalising healthcare practices in Malaysia). While we have yet to factor in any financial impact from the digital health ventures for the time being, we raise our FY21/22 earnings forecasts by 52.7/65.5% (amid a low base) to account for earnings recovery in Edgenta’s core businesses. After tweaking our SOP-derived valuation methodology and rolling over our valuation year, our TP rises to RM2.53 from RM2.00. Maintain BUY.

Edgenta’s core business currently involves facilities management for the healthcare and infrastructure sectors, which historically accounted for ~45% and ~35% of revenue over the previous 5 years. With Edgenta’s success in adopting technology in their healthcare support services operations, digital healthcare is the logical next step. In this report, we explore Edgenta’s planned digital healthcare ventures going forward.

QuickMed. QuickMed is a platform launched by Edgenta to help healthcare providers digitise their operations and connect to the internet (i.e. their target user base are healthcare providers). QuickMed’s digital solutions include storage of data on cloud, automation of billing, and more. We reckon Edgenta will need to acquire a sizeable user base before these ventures can be monetised effectively.

Potential longer-term business model. We believe QuickMed will be the start of a comprehensive digital healthcare journey. While it is still unclear what monetisation strategies Edgenta will purse, it may come in a few forms, namely: (i) subscription fees from healthcare providers using the QuickMed platform for operations, (ii) selling medical products to users online, (iii) charging fees for value adding services within the platform such as virtual consultations, (iv) charging referrals fees to clinics that patients find via Edgenta’s platforms, (v) selling membership packages to users, (vi) selling wellness packages to users.

Ideal management team. We are enthusiastic about Edgenta’s appointment of Mr. Syahrunizam Samsudin (Managing Director & CEO) in mid-FY20 given his formidable track record in launching and growing digital ventures. Note that during his time at Touch ‘N Go, Mr. Samsudin successfully launched TNG e-wallet as a JV with Ant Financial (affiliate company of Alibaba) which grew to become the largest e wallet in Malaysia.

Forecasts. As Edgenta’s digital healthcare ventures are still in its infancy, we do not factor in any financial impact from the digital health ventures for the time being. However, we raise our FY21/22 earnings forecasts by 52.7/65.5% (amid a low base) to account for earnings recovery from the Infrastructure services division from road maintenance works pushed back into FY21 from Covid-19 disruptions on operations in FY20.

Maintain BUY. We take this opportunity to roll over our valuation year and tweak our SOP valuation methodology (Figure #6). All in all, our TP rises to RM2.53 from RM2.00. In the shorter term, we reckon the share price will be driven by (i) recovery in the infrastructure services earnings from roadworks pushed back from FY20 (ii) projected FY21 healthy dividend yield of 4.8%.

Source: Hong Leong Investment Bank Research - 10 May 2021

Share this
Labels: EDGENTA

Related Stocks

Chart Stock Name Last Change Volume 
EDGENTA 1.80 +0.03 (1.69%) 264,600 

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

572  344  555 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FINTEC 0.035+0.005 
 MMAG 0.185-0.005 
 VSOLAR 0.02+0.005 
 EURO 1.10-0.11 
 MTOUCHE 0.090.00 
 SERBADK 0.625-0.005 
 HHHCORP 0.190.00 
 MRDIY 3.900.00 
 FOCUS 0.04+0.005 
 EDARAN 1.17+0.265 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. What Professor Dennis Etler said about China - Koon Yew Yin Koon Yew Yin's Blog
2. Why China is excluded in G7 summit? Koon Yew Yin Koon Yew Yin's Blog
3. AT Current Share Price: RM0.07. 1st Target Price: RM0.134, 2nd Target Price: RM0.28, 3rd Target Price: RM0.80 Fundamental Analysis of AT(0072) as at June 17 2021
4. UNCOMMON ACTIVITIES SPOTTED ON RECENT CORPORATE EXERCISE OF THIS COMPANY!! Swim With Sharks
5. Singapore sees first day rush for Sinovac vaccine; as 16 Covid-19 cases announced on Friday (June 18) Good Articles to Share
6. Serba Dinamik rombak struktur Lembaga Pengarah, lantik IIlyas Pakeer sebagai pengerusi Oil and Gas Malaysia News
7. [MUST READ] Important message for all investors who are planning to invest in AT or existing AT shareholders Important message for all investors who are planning to invest in AT or existing AT shareholders
8. SMetric (0203): A secured technical buy? - 17 June 2021 - Sujibaby Sujibaby Stock-Talk
PARTNERS & BROKERS